Table 2.

Estimated 2006 mean total and OOP drug costs before and after Part D, by ESRD statusa

EstimateWith ESRD (Unweighted n = 256)Without ESRD (Unweighted n = 41,361)P
Total drug spending$6488 ± 765$2705 ± 35<0.0001
OOP spending without Part D$2153 ± 255$1146 ± 180.0003
OOP spending under Part D$2329 ± 133$1311 ± 16<0.0001
Absolute change under Part D$176 ± 226$121 ± 200.81
  • a Data are means ± SEM. OOP, out-of-pocket.